Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
1.
Environ Microbiol ; 18(2): 557-64, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26486254

RESUMEN

We determined if antibiotics residues that are excreted from treated animals can contribute to persistence of resistant bacteria in agricultural environments. Administration of ceftiofur, a third-generation cephalosporin, resulted in a ∼ 3 log increase in ceftiofur-resistant Escherichia coli found in the faeces and pen soils by day 10 (P = 0.005). This resistant population quickly subsided in faeces, but was sustained in the pen soil (∼ 4.5 log bacteria g(-1)) throughout the trial (1 month). Florfenicol treatment resulted in a similar pattern although the loss of florfenicol-resistant E. coli was slower for faeces and remained stable at ∼ 6 log bacteria g(-1) in the soil. Calves were treated in pens where eGFP-labelled E. coli were present in the bedding (∼ 2 log g(-1)) resulting in amplification of the eGFP E. coli population ∼ 2.1 log more than eGFP E. coli populations in pens with untreated calves (day 4; P < 0.005). Excreted residues accounted for > 10-fold greater contribution to the bedding reservoir compared with shedding of resistant bacteria in faeces. Treatment with therapeutic doses of ceftiofur or florfenicol resulted in 2-3 log g(-1) more bacteria than the estimated ID50 (2.83 CFU g(-1)), consistent with a soil-borne reservoir emerging after antibiotic treatment that can contribute to the long-term persistence of antibiotic resistance in animal agriculture.


Asunto(s)
Antibacterianos/farmacología , Enfermedades de los Bovinos/tratamiento farmacológico , Cefalosporinas/farmacología , Farmacorresistencia Bacteriana/efectos de los fármacos , Infecciones por Escherichia coli/veterinaria , Escherichia coli/efectos de los fármacos , Microbiología del Suelo , Tianfenicol/análogos & derivados , Animales , Antibacterianos/metabolismo , Antibacterianos/uso terapéutico , Bovinos , Enfermedades de los Bovinos/microbiología , Cefalosporinas/metabolismo , Cefalosporinas/uso terapéutico , Residuos de Medicamentos/metabolismo , Residuos de Medicamentos/farmacología , Infecciones por Escherichia coli/tratamiento farmacológico , Infecciones por Escherichia coli/microbiología , Heces/microbiología , Oxitetraciclina/metabolismo , Oxitetraciclina/farmacología , Oxitetraciclina/uso terapéutico , Suelo , Tianfenicol/metabolismo , Tianfenicol/farmacología , Tianfenicol/uso terapéutico
2.
Appl Environ Microbiol ; 81(2): 658-65, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25381243

RESUMEN

Flavobacterium psychrophilum causes bacterial cold-water disease in multiple fish species, including salmonids. An autochthonous Enterobacter strain (C6-6) inhibits the in vitro growth of F. psychrophilum, and when ingested as a putative probiotic, it provides protection against injection challenge with F. psychrophilum in rainbow trout. In this study, low-molecular-mass (≤3 kDa) fractions from both Enterobacter C6-6 and Escherichia coli K-12 culture supernatants inhibited the growth of F. psychrophilum. The ≤3-kDa fraction from Enterobacter C6-6 was analyzed by SDS-PAGE, and subsequent tandem mass spectroscopy identified EcnB, which is a small membrane lipoprotein that is a putative pore-forming toxin. Agar plate diffusion assays demonstrated that ecnAB knockout strains of both Enterobacter C6-6 and E. coli K-12 no longer inhibited F. psychrophilum (P < 0.001), while ecnAB-complemented knockout strains recovered the inhibitory phenotype (P < 0.001). In fish experiments, the engineered strains (C6-6 ΔecnAB and C6-6 ΔecnAB) and the wild-type strain (C6-6) were added to the fish diet every day for 38 days. On day 11, the fish were challenged by injection with a virulent strain of F. psychrophilum (CSF 259-93). Fish that were fed C6-6 had significantly longer survival than fish fed the ecnAB knockout strain (P < 0.0001), while fish fed the complemented knockout strain recovered the probiotic phenotype (P = 0.61). This entericidin is responsible for the probiotic activity of Enterobacter C6-6, and it may present new opportunities for therapeutic and prophylactic treatments against similarly susceptible pathogens.


Asunto(s)
Infecciones Bacterianas/veterinaria , Proteínas Bacterianas/metabolismo , Enterobacter/metabolismo , Enfermedades de los Peces/prevención & control , Flavobacterium/crecimiento & desarrollo , Oncorhynchus mykiss/microbiología , Probióticos/administración & dosificación , Animales , Antibacterianos/aislamiento & purificación , Antibacterianos/metabolismo , Antibacterianos/farmacología , Antibiosis , Infecciones Bacterianas/prevención & control , Proteínas Bacterianas/aislamiento & purificación , Proteínas Bacterianas/farmacología , Frío , ADN Bacteriano/química , ADN Bacteriano/genética , Enterobacter/crecimiento & desarrollo , Escherichia coli K12/metabolismo , Flavobacterium/efectos de los fármacos , Espectrometría de Masas , Datos de Secuencia Molecular , Análisis de Secuencia de ADN
3.
Appl Environ Microbiol ; 81(20): 6953-63, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26209678

RESUMEN

The microcin PDI inhibits a diverse group of pathogenic Escherichia coli strains. Coculture of a single-gene knockout library (BW25113; n=3,985 mutants) against a microcin PDI-producing strain (E. coli 25) identified six mutants that were not susceptible (ΔatpA, ΔatpF, ΔdsbA, ΔdsbB, ΔompF, and ΔompR). Complementation of these genes restored susceptibility in all cases, and the loss of susceptibility was confirmed through independent gene knockouts in E. coli O157:H7 Sakai. Heterologous expression of E. coli ompF conferred susceptibility to Salmonella enterica and Yersinia enterocolitica strains that are normally unaffected by microcin PDI. The expression of chimeric OmpF and site-directed mutagenesis revealed that the K47G48N49 region within the first extracellular loop of E. coli OmpF is a putative binding site for microcin PDI. OmpR is a transcriptional regulator for ompF, and consequently loss of susceptibility by the ΔompR strain most likely is related to this function. Deletion of AtpA and AtpF, as well as AtpE and AtpH (missed in the original library screen), resulted in the loss of susceptibility to microcin PDI and the loss of ATP synthase function. Coculture of a susceptible strain in the presence of an ATP synthase inhibitor resulted in a loss of susceptibility, confirming that a functional ATP synthase complex is required for microcin PDI activity. In trans expression of ompF in the ΔdsbA and ΔdsbB strains did not restore a susceptible phenotype, indicating that these proteins are probably involved with the formation of disulfide bonds for OmpF or microcin PDI.


Asunto(s)
Antibacterianos/farmacología , Bacteriocinas/farmacología , Escherichia coli/efectos de los fármacos , Escherichia coli/genética , Sitios de Unión , Análisis Mutacional de ADN , Farmacorresistencia Bacteriana , Técnicas de Inactivación de Genes , Prueba de Complementación Genética , Pruebas Genéticas , Porinas/genética , Porinas/metabolismo , Unión Proteica , Salmonella enterica/efectos de los fármacos , Salmonella enterica/genética , Yersinia enterocolitica/efectos de los fármacos , Yersinia enterocolitica/genética
4.
BMC Microbiol ; 15: 179, 2015 Sep 16.
Artículo en Inglés | MEDLINE | ID: mdl-26377311

RESUMEN

BACKGROUND: Flavobacterium psychrophilum is the etiologic agent of bacterial coldwater disease in salmonids. Earlier research showed that a rifampicin-passaged strain of F. psychrophilum (CSF 259-93B.17) caused no disease in rainbow trout (Oncorhynchus mykiss, Walbaum) while inducing a protective immune response against challenge with the virulent CSF 259-93 strain. We hypothesized that rifampicin passage leads to an accumulation of genomic mutations that, by chance, reduce virulence. To assess the pattern of phenotypic and genotypic changes associated with passage, we examined proteomic, LPS and single-nucleotide polymorphism (SNP) differences for two F. psychrophilum strains (CSF 259-93 and THC 02-90) that were passaged with and without rifampicin selection. RESULTS: Rifampicin resistance was conveyed by expected mutations in rpoB, although affecting different DNA bases depending on the strain. One rifampicin-passaged CSF 259-93 strain (CR) was attenuated (4 % mortality) in challenged fish, but only accumulated eight nonsynonymous SNPs compared to the parent strain. A CSF 259-93 strain passaged without rifampicin (CN) accumulated five nonsynonymous SNPs and was partially attenuated (28 % mortality) compared to the parent strain (54.5 % mortality). In contrast, there were no significant change in fish mortalities among THC 02-90 wild-type and passaged strains, despite numerous SNPs accumulated during passage with (n = 174) and without rifampicin (n = 126). While only three missense SNPs were associated with attenuation, a Ser492Phe rpoB mutation in the CR strain may contribute to further attenuation. All strains except CR retained a gliding motility phenotype. Few proteomic differences were observed by 2D SDS-PAGE and there were no apparent changes in LPS between strains. Comparative methylome analysis of two strains (CR and TR) identified no shared methylation motifs for these two strains. CONCLUSION: Multiple genomic changes arose during passage experiments with rifampicin selection pressure. Consistent with our hypothesis, unique strain-specific mutations were detected for the fully attenuated (CR), partially attenuated (CN) and another fully attenuated strain (B17).


Asunto(s)
Antibacterianos/metabolismo , Farmacorresistencia Bacteriana , Infecciones por Flavobacteriaceae/veterinaria , Flavobacterium/efectos de los fármacos , Flavobacterium/crecimiento & desarrollo , Rifampin/metabolismo , Animales , ARN Polimerasas Dirigidas por ADN/genética , Enfermedades de los Peces/microbiología , Infecciones por Flavobacteriaceae/microbiología , Flavobacterium/patogenicidad , Lipopolisacáridos/análisis , Datos de Secuencia Molecular , Oncorhynchus mykiss , Polimorfismo de Nucleótido Simple , Proteoma/análisis , Selección Genética , Análisis de Secuencia de ADN , Pase Seriado , Análisis de Supervivencia , Virulencia
5.
Appl Environ Microbiol ; 80(24): 7521-6, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25261519

RESUMEN

Biosolids and livestock manure are valuable high-carbon soil amendments, but they commonly contain antibiotic residues that might persist after land application. While composting reduces the concentration of extractable antibiotics in these materials, if the starting concentration is sufficiently high then remaining residues could impact microbial communities in the compost and soil to which these materials are applied. To examine this issue, ciprofloxacin was added to biosolid compost feedstock to achieve a total concentration of 19 ppm, approximately 5-fold higher than that normally detected by liquid chromatography-tandem mass spectrometry (LC-MS/MS) (1 to 3.5 ppm). This feedstock was placed into mesh bags that were buried in aerated compost bays. Once a week, a set of bags was removed and analyzed (treated and untreated, three replicates of each; 4 weeks). Addition of ciprofloxacin had no effect on the recovery of resistant bacteria at any time point (P = 0.86), and a separate bioassay showed that aqueous extractions from materials with an estimated 59 ppm ciprofloxacin had no effect on the growth of a susceptible strain of Escherichia coli (P = 0.28). Regression analysis showed that growth of the susceptible strain of E. coli can be reduced given a sufficiently high concentration of ciprofloxacin (P < 0.007), a result that is consistent with adsorption being the primary mechanism of sequestration. While analytical methods detected biologically significant concentrations of ciprofloxacin in the materials tested here, the culture-based methods were consistent with the materials having sufficient adsorptive capacity to prevent typical concentrations of ciprofloxacin residues from selectively enriching populations of resistant bacteria.


Asunto(s)
Antibacterianos/farmacología , Bacterias/efectos de los fármacos , Ciprofloxacina/farmacología , Residuos de Medicamentos/farmacología , Microbiología del Suelo , Antibacterianos/análisis , Ciprofloxacina/análisis , Residuos de Medicamentos/análisis , Farmacorresistencia Bacteriana , Estiércol/análisis , Suelo/química , Residuos/análisis
6.
Appl Environ Microbiol ; 78(9): 3492-4, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22389365

RESUMEN

We employed a heterologous secretion assay to identify proteins potentially secreted by type III secretion systems (T3SSs) in Vibrio parahaemolyticus. N-terminal sequences from 32 proteins within T3SS genomic islands and seven proteins from elsewhere in the chromosome included proteins that were recognized for export by the Yersinia enterocolitica flagellar T3SS.


Asunto(s)
Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Sistemas de Secreción Bacterianos/genética , Yersinia enterocolitica/genética , Yersinia enterocolitica/metabolismo , ADN Bacteriano/química , ADN Bacteriano/genética , Expresión Génica , Datos de Secuencia Molecular , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Análisis de Secuencia de ADN , Vibrio parahaemolyticus/genética , Vibrio parahaemolyticus/metabolismo
7.
Microbiology (Reading) ; 157(Pt 5): 1428-1445, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21292746

RESUMEN

Salmonella enterica serovar Enteritidis (S. Enteritidis) is a major cause of food-borne gastroenteritis in humans worldwide. Poultry and poultry products are considered the major vehicles of transmission to humans. Using cell invasiveness as a surrogate marker for pathogenicity, we tested the invasiveness of 53 poultry-associated isolates of S. Enteritidis in a well-differentiated intestinal epithelial cell model (Caco-2). The method allowed classification of the isolates into low (n = 7), medium (n = 18) and high (n = 30) invasiveness categories. Cell invasiveness of the isolates did not correlate with the presence of the virulence-associated gene spvB or the ability of the isolates to form biofilms. Testing of representative isolates with high and low invasiveness in a mouse model revealed that the former were more invasive in vivo and caused more and earlier mortalities, whereas the latter were significantly less invasive in vivo, causing few or no mortalities. Further characterization of representative isolates with low and high invasiveness showed that most of the isolates with low invasiveness had impaired motility and impaired secretion of either flagella-associated proteins (FlgK, FljB and FlgL) or type III secretion system (TTSS)-secreted proteins (SipA and SipD) encoded on Salmonella pathogenicity island-1. In addition, isolates with low invasiveness had impaired ability to invade and/or survive within chicken macrophages. These data suggest that not all isolates of S. Enteritidis recovered from poultry may be equally pathogenic, and that the pathogenicity of S. Enteritidis isolates is associated, in part, with both motility and secretion of TTSS effector proteins.


Asunto(s)
Proteínas Bacterianas/metabolismo , Enfermedades de las Aves de Corral/microbiología , Salmonelosis Animal/microbiología , Infecciones por Salmonella/microbiología , Salmonella enteritidis/fisiología , Salmonella enteritidis/patogenicidad , Animales , Proteínas Bacterianas/genética , Biopelículas , Células CACO-2 , Pollos , Femenino , Contaminación de Alimentos , Islas Genómicas , Humanos , Estimación de Kaplan-Meier , Carne/microbiología , Ratones , Ratones Endogámicos BALB C , Modelos Biológicos , Datos de Secuencia Molecular , Filogenia , Transporte de Proteínas , Infecciones por Salmonella/mortalidad , Salmonelosis Animal/mortalidad , Salmonella enteritidis/clasificación , Salmonella enteritidis/genética , Virulencia , Factores de Virulencia/genética , Factores de Virulencia/metabolismo
8.
Appl Environ Microbiol ; 77(10): 3293-9, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21421795

RESUMEN

We hypothesized that bacterial populations growing in the absence of antibiotics will accumulate more resistance gene mutations than bacterial populations growing in the presence of antibiotics. If this is so, the prevalence of dysfunctional resistance genes (resistance pseudogenes) could provide a measure of the level of antibiotic exposure present in a given environment. As a proof-of-concept test, we assayed field strains of Escherichia coli for their resistance genotypes using a resistance gene microarray and further characterized isolates that had resistance phenotype-genotype discrepancies. We found a small but significant association between the prevalence of isolates with resistance pseudogenes and the lower antibiotic use environment of a beef cow-calf operation versus a higher antibiotic use dairy calf ranch (Fisher's exact test, P = 0.044). Other significant findings include a very strong association between the dairy calf ranch isolates and phenotypes unexplained by well-known resistance genes (Fisher's exact test, P < 0.0001). Two novel resistance genes were discovered in E. coli isolates from the dairy calf ranch, one associated with resistance to aminoglycosides and one associated with resistance to trimethoprim. In addition, isolates resistant to expanded-spectrum cephalosporins but negative for bla(CMY-2) had mutations in the promoter regions of the chromosomal E. coli ampC gene consistent with reported overexpression of native AmpC beta-lactamase. Similar mutations in hospital E. coli isolates have been reported worldwide. Prevalence or rates of E. coli ampC promoter mutations may be used as a marker for high expanded-spectrum cephalosporin use environments.


Asunto(s)
Antibacterianos/farmacología , Enfermedades de los Bovinos/tratamiento farmacológico , Enfermedades de los Bovinos/microbiología , Farmacorresistencia Bacteriana , Infecciones por Escherichia coli/veterinaria , Escherichia coli/efectos de los fármacos , Animales , Antibacterianos/uso terapéutico , Bovinos , ADN Bacteriano/química , ADN Bacteriano/genética , Escherichia coli/aislamiento & purificación , Infecciones por Escherichia coli/tratamiento farmacológico , Infecciones por Escherichia coli/microbiología , Proteínas de Escherichia coli/genética , Genes Bacterianos , Genotipo , Datos de Secuencia Molecular , Mutación , Análisis de Secuencia de ADN
9.
Infect Immun ; 78(11): 4551-9, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-20823199

RESUMEN

Vibrio parahaemolyticus is an emerging food- and waterborne pathogen that encodes two type III secretion systems (T3SSs). Previous studies have linked type III secretion system 1 (T3SS1) to cytotoxicity and T3SS2 to intestinal fluid accumulation, but animal challenge models needed to study these phenomena are limited. In this study we evaluated the roles of the T3SSs during infection using two novel animal models: a model in which piglets were inoculated orogastrically and a model in which mice were inoculated in their lungs (intrapulmonarily). The bacterial strains employed in this study had equivalent growth rates and beta-hemolytic activity based on in vitro assays. Inoculation of 48-h-old conventional piglets with 10(11) CFU of the wild-type strain (NY-4) or T3SS1 deletion mutant strains resulted in acute, self-limiting diarrhea, whereas inoculation with a T3SS2 deletion mutant strain failed to produce any clinical symptoms. Intrapulmonary inoculation of C57BL/6 mice with the wild-type strain and T3SS2 deletion mutant strains (5 × 10(5) CFU) induced mortality or a moribund state within 12 h (80 to 100% mortality), whereas inoculation with a T3SS1 deletion mutant or a T3SS1 T3SS2 double deletion mutant produced no mortality. Bacteria were recovered from multiple organs regardless of the strain used in the mouse model, indicating that the mice were capable of clearing the lung infection in the absence of a functional T3SS1. Because all strains had a similar beta-hemolysin phenotype, we surmise that thermostable direct hemolysin (TDH) plays a limited role in these models. The two models introduced herein produce robust results and provide a means to determine how different T3SS1 and T3SS2 effector proteins contribute to pathogenesis of V. parahaemolyticus infection.


Asunto(s)
Proteínas Bacterianas/metabolismo , Modelos Animales de Enfermedad , Vibriosis/patología , Vibrio parahaemolyticus/patogenicidad , Animales , Animales Recién Nacidos , Proteínas Bacterianas/genética , Diarrea/microbiología , Diarrea/mortalidad , Diarrea/patología , Femenino , Enfermedades Gastrointestinales/microbiología , Enfermedades Gastrointestinales/mortalidad , Enfermedades Gastrointestinales/patología , Regulación Bacteriana de la Expresión Génica , Humanos , Pulmón/microbiología , Enfermedades Pulmonares/microbiología , Enfermedades Pulmonares/mortalidad , Enfermedades Pulmonares/patología , Masculino , Ratones , Ratones Endogámicos C57BL , Porcinos , Vibriosis/microbiología , Vibriosis/mortalidad , Vibrio parahaemolyticus/genética , Vibrio parahaemolyticus/metabolismo , Virulencia , Factores de Virulencia/genética , Factores de Virulencia/metabolismo
10.
Antimicrob Agents Chemother ; 54(6): 2666-9, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20368404

RESUMEN

Bovine-origin Escherichia coli isolates were tested for resistance phenotypes using a disk diffusion assay and for resistance genotypes using a DNA microarray. An isolate with gentamicin and amikacin resistance but with no corresponding genes detected yielded a 1,056-bp DNA sequence with the closest homologues for its inferred protein sequence among a family of 16S rRNA methyltransferase enzymes. These enzymes confer high-level aminoglycoside resistance and have only recently been described in Gram-negative bacteria.


Asunto(s)
Farmacorresistencia Bacteriana Múltiple/genética , Escherichia coli/efectos de los fármacos , Escherichia coli/genética , Genes Bacterianos , Animales , Secuencia de Bases , Bovinos , Cartilla de ADN/genética , ADN Bacteriano/genética , Escherichia coli/aislamiento & purificación , Escherichia coli/metabolismo , Técnicas In Vitro , Metiltransferasas/clasificación , Metiltransferasas/genética , Análisis de Secuencia por Matrices de Oligonucleótidos , Filogenia , ARN Bacteriano/metabolismo , ARN Ribosómico 16S/metabolismo
11.
Antimicrob Agents Chemother ; 54(2): 590-6, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19949054

RESUMEN

Large multidrug resistance plasmids of the A/C incompatibility complex (IncA/C) have been found in a diverse group of Gram-negative commensal and pathogenic bacteria. We present three completed sequences from IncA/C plasmids that originated from Escherichia coli (cattle) and Salmonella enterica serovar Newport (human) and that carry the cephamycinase gene blaCMY-2. These large plasmids (148 to 166 kbp) share extensive sequence identity and synteny. The most divergent plasmid, peH4H, has lost several conjugation-related genes and has gained a kanamycin resistance region. Two of the plasmids (pAM04528 and peH4H) harbor two copies of blaCMY-2, while the third plasmid (pAR060302) harbors a single copy of the gene. The majority of single-nucleotide polymorphisms comprise nonsynonymous mutations in floR. A comparative analysis of these plasmids with five other published IncA/C plasmids showed that the blaCMY-2 plasmids from E. coli and S. enterica are genetically distinct from those originating from Yersinia pestis and Photobacterium damselae and distal to one originating from Yersinia ruckeri. While the overall similarity of these plasmids supports the likelihood of recent movements among E. coli and S. enterica hosts, their greater divergence from Y. pestis or Y. ruckeri suggests less recent plasmid transfer among these pathogen groups.


Asunto(s)
Escherichia coli/genética , Plásmidos/genética , Salmonella enterica/genética , beta-Lactamasas/genética , Farmacorresistencia Bacteriana Múltiple/genética , Photobacterium/genética , Filogenia , Plásmidos/clasificación , Polimorfismo de Nucleótido Simple/genética , Yersinia pestis/genética
12.
Immunogenetics ; 62(9): 633-9, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20683590

RESUMEN

Development of an accurate and efficient molecular-based equine MHC class I typing method would facilitate the study of T lymphocyte immune responses in horses. Here, a DNA microarray was designed to detect expressed classical MHC class I genes comprising serologically defined equine leukocyte antigen (ELA)-A haplotypes represented in a closed Arabian horse breeding herd. Initially, cloning and sequencing of RT-PCR products were used to identify sequences associated with the ELA-A1, A4, and W11 haplotypes, and one undefined haplotype, in six horses. Subsequently, sequence-specific, conserved (positive control), and random nucleotide (negative control) 23- to 27-mer oligonucleotide microarray probes were designed and spotted onto an epoxy-coated masked slide using a robotic arrayer. Bulk RT-PCR products from each horse were biotinylated by nick translation, hybridized to the array, and detected using tyramide signal amplification. The microarray consistently detected eight of nine classical MHC class I transcripts and allowed ELA haplotypic associations to be made. Cloning and sequencing of RT-PCR products were then performed in a group of ELA disparate horses and ponies, in which six novel sequences were identified. This group was used to determine the specificity of the array. Overall, the microarray was more efficient than cloning and sequencing for detecting expressed classical MHC class I sequences in this defined population of horses, and was significantly more specific than serology. These results confirmed the utility of a microarray-based method for high-resolution MHC class I typing in the horse. With additional probes the array could be useful in a broader population.


Asunto(s)
Biomarcadores/metabolismo , Perfilación de la Expresión Génica , Genes MHC Clase I/genética , Haplotipos/genética , Caballos/genética , Análisis de Secuencia por Matrices de Oligonucleótidos , Animales , ARN Mensajero/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
13.
Foodborne Pathog Dis ; 5(4): 505-16, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18713065

RESUMEN

Comparative-omics will identify a multitude of markers that can be used for intraspecific discrimination between strains of bacteria. It seems intuitive that with this plethora of markers we can construct higher resolution subtyping assays using discrete markers to define strain "barcodes." Unfortunately, with each new marker added to an assay, overall assay robustness declines because errors are compounded exponentially. For example, the difference in accuracy of strain classification for an assay with 60 markers will change from 99.9% to 54.7% when average probe accuracy declines from 99.999% to 99.0%. To illustrate this effect empirically, we constructed a 19 probe bead-array for subtyping Listeria monocytogenes and showed that despite seemingly reliable individual probe accuracy (>97%), our best classification results at the strain level were <75%. A more robust strategy would use as few markers as possible to achieve strain discrimination. Consequently, we developed two variable number of tandem repeat (VNTR) assays (Vibrio parahaemolyticus and L. monocytogenes) and demonstrate that these assays along with a published assay (Salmonella enterica) produce robust results when products were machine scored. The discriminatory ability with four to seven VNTR loci was comparable to pulsed-field gel electrophoresis. Passage experiments showed some instability with ca. 5% of passaged lines showing evidence for new alleles within 30 days (V. parahaemolyticus and S. enterica). Changes were limited to a single locus and allele so conservative rules can be used to determine strain matching. Most importantly, VNTRs appear robust and portable and can clearly discriminate between strains with relatively few loci thereby limiting effects of compounding error.


Asunto(s)
Técnicas de Tipificación Bacteriana/métodos , Marcadores Genéticos , Repeticiones de Minisatélite , Hibridación de Ácido Nucleico/métodos , Alelos , Sondas de ADN , ADN Bacteriano/genética , Electroforesis en Gel de Campo Pulsado/métodos , Genes Bacterianos , Listeria monocytogenes/clasificación , Listeria monocytogenes/genética , Microesferas , Reacción en Cadena de la Polimerasa , Salmonella enterica/clasificación , Salmonella enterica/genética , Sensibilidad y Especificidad , Especificidad de la Especie , Vibrio parahaemolyticus/clasificación , Vibrio parahaemolyticus/genética
14.
Sci Rep ; 7: 42529, 2017 02 16.
Artículo en Inglés | MEDLINE | ID: mdl-28205647

RESUMEN

Microcin PDI inhibits a diversity of pathogenic Escherichia coli through the action of an effector protein, McpM. In this study we demonstrated that expression of the inhibitory phenotype is induced under low osmolarity conditions and expression is primarily controlled by the EnvZ/OmpR two-component regulatory system. Functional, mutagenesis and complementation experiments were used to empirically demonstrate that EnvZ is required for the inhibitory phenotype and that regulation of mcpM is dependent on binding of the phosphorylated OmpR to the mcpM promoter region. The phosphorylated OmpR may recognize three different binding sites within this promoter region. Site-directed mutagenesis revealed that the McpM precursor peptide includes two leader peptides that undergo sequential cleavage at positions G17/G18 and G35/A36 during export through the type I secretion system. Competition assays showed that both cleaved products are required for the PDI phenotype although we could not distinguish loss of function from loss of secretion in these assays. McpM has four cysteines within the mature peptide and site-directed mutagenesis experiments demonstrated that the first two cysteines are necessary for McpM to inhibit susceptible cells. Together these data combined with previous work indicate that MccPDI is unique amongst the microcins that have been described to date.


Asunto(s)
Bacteriocinas/genética , Bacteriocinas/metabolismo , Regulación Bacteriana de la Expresión Génica , Proteínas de la Membrana Bacteriana Externa/metabolismo , Proteínas Bacterianas/metabolismo , Bacteriocinas/química , Secuencia de Bases , Sitios de Unión , Escherichia coli/genética , Escherichia coli/metabolismo , Proteínas de Escherichia coli/genética , Proteínas de Escherichia coli/metabolismo , Técnicas de Inactivación de Genes , Prueba de Complementación Genética , Complejos Multienzimáticos/metabolismo , Fragmentos de Péptidos/metabolismo , Fenotipo , Fosforilación , Regiones Promotoras Genéticas , Unión Proteica , Transporte de Proteínas , Proteolisis , Transactivadores/metabolismo
15.
Artículo en Inglés | MEDLINE | ID: mdl-27999769

RESUMEN

Type III secretion systems (T3SSs) contribute to microbial pathogenesis of Vibrio species, but the regulatory mechanisms are complex. We determined if the classic ExsACDE protein-protein regulatory model from Pseudomonas aeruginosa applies to Vibrio alginolyticus. Deletion mutants in V. alginolyticus demonstrated that, as expected, the T3SS is positively regulated by ExsA and ExsC and negatively regulated by ExsD and ExsE. Interestingly, deletion of exsE enhanced the ability of V. alginolyticus to induce host-cell death while cytotoxicity was inhibited by in trans complementation of this gene in a wild-type strain, a result that differs from a similar experiment with Vibrio parahaemolyticus ExsE. We further showed that ExsE is a secreted protein that does not contribute to adhesion to Fathead minnow epithelial cells. An in vitro co-immunoprecipitation assay confirmed that ExsE binds to ExsC to exert negative regulatory effect on T3SS genes. T3SS in V. alginolyticus can be activated in the absence of physical contact with host cells and a separate regulatory pathway appears to contribute to the regulation of ExsA. Consequently, like ExsE from P. aeruginosa, ExsE is a negative regulator for T3SS gene expression in V. alginolyticus. Unlike the V. parahaemolyticus orthologue, however, deletion of exsE from V. alginolyticus enhanced in vitro cytotoxicity.


Asunto(s)
Regulación Bacteriana de la Expresión Génica , Proteínas Represoras/metabolismo , Sistemas de Secreción Tipo III/metabolismo , Vibrio alginolyticus/genética , Vibrio alginolyticus/metabolismo , Animales , Adhesión Bacteriana , Supervivencia Celular , Células Cultivadas , Cyprinidae , Células Epiteliales/microbiología , Eliminación de Gen , Prueba de Complementación Genética , Inmunoprecipitación , Unión Proteica , Proteínas Represoras/genética
16.
Bioresour Technol ; 192: 689-95, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26094195

RESUMEN

The aim of this work was to elucidate the mechanism of mediated microbial electrosynthesis via neutral red from an electrode to fermenting Escherichia coli cultures in a bioelectrochemical system. Chemical reduction of NAD(+) by reduced neutral red did not occur as predicted. Instead, neutral red was shown to reduce the menaquinone pool in the inner bacterial membrane. The reduced menaquinone pool altered fermentative metabolite production via the arcB redox-sensing cascade in the absence of terminal electron acceptors. When the acceptors DMSO, fumarate, or nitrate were provided, as many as 19% of the electrons trapped in the reduced acceptors were derived from the electrode. These results demonstrate the mechanism of neutral red-mediated microbial electrosynthesis during fermentation as well as how neutral red enables microbial electrosynthesis of reduced terminal electron acceptors.


Asunto(s)
Reactores Biológicos/microbiología , Estimulación Eléctrica/instrumentación , Escherichia coli/metabolismo , Rojo Neutro/metabolismo , Vitamina K 2/metabolismo , Estimulación Eléctrica/métodos , Campos Electromagnéticos , Diseño de Equipo , Escherichia coli/efectos de la radiación , Oxidación-Reducción
17.
J Microbiol Methods ; 82(1): 36-41, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20362014

RESUMEN

A microarray was developed to simultaneously screen Escherichia coli and Salmonella enterica for multiple genetic traits. The final array included 203 60-mer oligonucleotide probes, including 117 for resistance genes, 16 for virulence genes, 25 for replicon markers, and 45 other markers. Validity of the array was tested by assessing inter-laboratory agreement among four collaborating groups using a blinded study design. Internal validation indicated that the assay was reliable (area under the receiver-operator characteristic curve=0.97). Inter-laboratory agreement, however, was poor when estimated using the intraclass correlation coefficient, which ranged from 0.27 (95% confidence interval 0.24, 0.29) to 0.29 (0.23, 0.34). These findings suggest that extensive testing and procedure standardization will be needed before bacterial genotyping arrays can be readily shared between laboratories.


Asunto(s)
Proteínas Bacterianas/genética , Farmacorresistencia Bacteriana Múltiple , Escherichia coli/genética , Análisis de Secuencia por Matrices de Oligonucleótidos/métodos , Salmonella enterica/genética , Factores de Virulencia/genética , Antibacterianos/farmacología , Escherichia coli/efectos de los fármacos , Escherichia coli/aislamiento & purificación , Pruebas de Sensibilidad Microbiana , Salmonella enterica/efectos de los fármacos , Salmonella enterica/aislamiento & purificación
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda